Blogopmaak

DCRT presents ''oversees'' in Hyderabad and London

The Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad (India), organized a one-day symposium on the 27th January 2022 with some great speakers. Prof. Dr. Annemieke Aartsma-Rus was invited and presented the work and future plans of the DCRT. Would you like to listen to her talk? You can find the link to the recording in the Events & Talk section.


It has been a busy week as Annemieke also presented at the Festival of Genomics and Biodata (London, UK) on Thursday 26th January. This highlights one of the DCRT’s goals, namely to spread knowledge and educate researchers and clinicians worldwide on the work we do. For more talks on the DCRT, please check our website regularly!


published on Jan 27, 2022



by duda-wsm 26 Sept, 2024
Two new DCRT papers have been published online
by duda-wsm 08 Aug, 2024
Team DCRT went for its annual outing to Leiden's escape rooms
by duda-wsm 08 Aug, 2024
N=1 Collaborative is looking for communication trainees
by duda-wsm 07 Aug, 2024
PhD Position in treatment-response fluid biomarkers for ASO treatments
by duda-wsm 07 Aug, 2024
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
by duda-wsm 31 Jul, 2024
DCRT travel grants awarded to 3 PhD students
Dr. Marlen Lauffer, senior researcher at the DCRT, at the Genomics England research summit
by duda-wsm 10 Jul, 2024
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
by duda-wsm 01 May, 2024
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
by duda-wsm 22 Apr, 2024
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
by duda-wsm 10 Apr, 2024
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
More posts
Share by: